Forge Therapeutics

company

About

Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$15M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Forge Therapeutics, Inc is a biotechnology company discovering and developing novel therapeutics using an innovative chemistry platform targeting metalloproteins. Forge uses a proprietary approach combining bioinorganic (study of metals in biology) and medicinal chemistry to generate selective inhibitors of this large class of targets.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Forge Therapeutics has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Apr 25, 2017 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 25, 2017 Series A $15M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Forge Therapeutics is funded by 1 investors. Evotec are the most recent investors.
Investor Name Lead Investor Funding Round
Evotec Series A